Bicanalicular Silicone Intubation for the Management of Punctal Stenosis and Obstruction in Patients With Allergic Conjunctivitis

2019 ◽  
Vol 35 (5) ◽  
pp. 451-455 ◽  
Author(s):  
Naif Alsulaiman ◽  
Adel H. Alsuhaibani
Keyword(s):  
Allergic Conjunctivitis ◽  
Silicone Intubation ◽  
Punctal Stenosis

scholarly journals Treatment of bilateral punctal stenosis and nasolacrimal duct obstruction in an 11-year-old case with dyskeratosis congenita

2020 ◽  
Vol 3 ◽  
pp. 6
Author(s):  
Fatma Corak Eroglu ◽  
Emine Sen ◽  
Suleyman Ellik
Keyword(s):  
Skin Pigmentation ◽  
Dyskeratosis Congenita ◽  
Nasolacrimal Duct ◽  
Nasolacrimal Duct Obstruction ◽  
Telomere Maintenance ◽  
Long Term Results ◽  
Duct Obstruction ◽  
Silicone Intubation ◽  
Punctal Stenosis

The purpose of this study was to report the external dacryocystorhinostomy (ext-DCR) using silicone intubation in a child with dyskeratosis congenita (DC) who had presented by bilaterally acquired nasolacrimal duct obstruction (NLDO), punctal stenosis, and mucocutaneous changes. We report the 13-month results of an 11-year-old boy with DC who underwent bilateral ext-DCR with silicone stenting under general anesthesia. Ophthalmic examination revealed bilateral punctal stenosis and NLDO with normal fundus examination. He was referred to pediatrics and was diagnosed as DC, based on classic reticular skin pigmentation, nail dystrophy, and oral leukoplakia, without any other systemic involvement. Treatment consisted of bilateral ext-DCR using silicone stenting by 6 months. Management of surgery and post-operative 13-month follow up results was observed. DC is a rare heterogeneous multisystem disorder of telomere maintenance, which may present with ophthalmologic features. Although the lacrimal system abnormalities have been reported most frequently ocular findings in DC, this is the first case to present the management and long-term results of DCR using silicone intubation. This case aims to raise awareness of the various systemic and ocular manifestations and possible complications of DC and to present long-term results of ext-DC in a patient with DC.

scholarly journals Rectangular 3-snip punctoplasty versus punch punctoplasty with silicone intubation for acquired external punctal stenosis: a prospective randomized comparative study

2021 ◽  
Vol 14 (6) ◽  
pp. 849-854
Author(s):  
Xin Cao ◽  
◽  
Ying Wu ◽  
Yu Song ◽  
Qing-Huai Liu ◽  
...  
Keyword(s):  
Comparative Study ◽  
Group A ◽  
Silicone Intubation ◽  
Time Test ◽  
Fluorescein Dye ◽  
Tear Meniscus ◽  
Tear Meniscus Height ◽  
Group B ◽  
Anatomical Success ◽  
Punctal Stenosis

AIM: To evaluate the effectiveness of rectangular 3-snip punctoplasty versus punch punctoplasty via Kelly punch with silicone intubation for the management of acquired external punctal stenosis (AEPS). METHODS: A prospective, randomized, comparative study was performed on 123 eyes of 94 patients with AEPS. Patients were recruited into either group of rectangular 3-snip punctoplasty (group A) or group of punch punctoplasty with silicone intubation (group B). Outcomes measured were Munk score, grade of punctal stenosis, fluorescein dye disappearance time test (FDDT) and tear meniscus height (TMH) 6 and 12mo after surgery. RESULTS: Twelve months after surgery, Munk score, FDDT and TMH significantly decreased in both groups compared with the baseline (all P<0.05), and grade of punctal stenosis increased significantly (P<0.05). The grade of punctal stenosis, Munk score, FDDT and TMH were better in group B compared with group A at 6 or 12mo (all P<0.05). There was a positive correlation between TMH and Munk score (R=0.655, P<0.001). At the last followed-up, anatomical success was noted in 96.7% eyes in group A and 98.4% eyes in group B (P=0.613). CONCLUSION: Punch punctoplasty via Kelly punch with silicone intubation achieves better outcomes than rectangular 3-snip punctoplasty. The new technique is a simple, minimally invasive, with high anatomical and functional success in patients with AEPS.

Elevated levels of substance P in tears of patients with allergic conjunctivitis and vernal keratoconjunctivitis

1997 ◽  
Vol 27 (4) ◽  
pp. 372-378 ◽  
Author(s):  
H. FUJISHIMA ◽  
M. TAKEYAMA ◽  
T. TAKEUCHI ◽  
I. SAITO ◽  
K. TSUBOTA
Keyword(s):  
Substance P ◽  
Allergic Conjunctivitis ◽  
Vernal Keratoconjunctivitis

НОВЫЕ ВОЗМОЖНОСТИ КОМБИНИРОВАННОЙ ТЕРАПИИ АЛЛЕРГИЧЕСКОГО РИНИТА В УСЛОВИЯХ РЕАЛЬНОЙ КЛИНИЧЕСКОЙ ПРАКТИКИ

2019 ◽  
Author(s):  
E.V. Nazarova
Keyword(s):  
Allergic Conjunctivitis ◽  
Nasal Congestion ◽  
Nasal Breathing ◽  
Interferon Alpha 2B ◽  
Complex Therapy ◽  
Eye Symptoms ◽  
Low Incidence ◽  
The Given ◽  
Combined Medication ◽  
Real Clinical Practice

Статья представляет собой обзор исследовательской программы по оценке эффективности оригинального комбинированного лекарственного препарата Аллергоферон бета (бетаметазон интерферон альфа-2b) в условиях реальной клинической практики у больных сезонным аллергическим ринитом (АР). Результаты программы продемонстрировали хорошую эффективность препарата: при низкой частоте побочных эффектов наблюдалось снижение заложенности носа и восстановление носового дыхания, у пациентов с сопутствующим аллергическим конъюнктивитом отмечалось снижение выраженности глазных симптомов. Было показано, что Аллергоферон бета может быть рекомендован в качестве монотерапии у больных АР с легким и среднетяжелым течением заболевания и в комплексной терапии при тяжелом течении АР.This paper assesses the efficacy of the original combined medication Allergoferon beta (betamethasone interferon alpha-2b) in real clinical practice among patients with seasonal allergic rhinitis (AR). The research program results demonstrated a good efficacy of the given medication: there were a decrease in nasal congestion as well as restoration of nasal breathing and in patients with concomitant allergic conjunctivitis - a reduction in the severity of eye symptoms. A low incidence of side effects was observed. It was shown that Allergoferon beta can be recommended as monotherapy for patients with mild and moderate AR and in complex therapy for patients with severe AR.

Sign in / Sign up

Export Citation Format

Share Document